Generation of Dendritic Cells from Positively Selected CD14⁺ Monocytes for Anti-tumor Immunotherapy

Reference

• Bancherau, J. and Steinman, R.M. (1998) "Dendritic cells and the control of immunity", Nature, 392, 245–252.
   PubMed Web of Science ®Google Scholar
• Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., et al. (1998) "Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells", Nature Medicine, 4, 328 — 332.
   Google Scholar
• Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., et al. (1999) "Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induce regression of some metastates in advanced stage IV melanoma", Journal of Experimental Medicine, 190, 1669–1678.
   PubMed Web of Science ®Google Scholar
• Brossart, P., Wirths, S., Stuhler, G., Reichardt, V.L., Kanz, L. and Brugger, W. (2000) "Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells", Blood, 96, 3102–3108.
   Google Scholar
• Fong, L., Brockstedt, D., Benike, C., Wu, L. and Engleman, E.G. (2001) "Dendritic cells injected via different routes induce immunity in cancer patients", Journal of Immunology, 166, 4254 — 4259.
   Google Scholar
• Hsu, F.J., Benike, C., Fagnoni, F., Liles, TM., Czerwinslci, D., Taidi, B., et al. (1996) "Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells", Nature Medicine, 2, 52 — 58.
   Google Scholar
• Reichardt, V.L., Okada, C.Y., Liso, A., Benike, CJ., Stockerl-Goldstein, K.E., Engleman, E.G., et al. (1999) "Idiotype vaccina-tion using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma- A feasibility study", Blood, 93, 2411–2419.
   PubMed Web of Science ®Google Scholar
• Timmerman, J.M., Czerwinslci, D.K., Davis, TA., Hsu, F.J., Benike, C., Hao, Z.M., et al. (2002) "Idiotype pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients", Blood, 99, 1517 — 1526.
   Web of Science ®Google Scholar
• Wen, Y.J., Ling, M., Wood-Bailey, R. and Lim, S.H. (1998) "Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma", Clinical Cancer Research, 4, 957 — 962.
   Google Scholar
• Titzer, S., Christensen, 0., Manzke, 0., Tesch, H., Wolf, J., Emmerich, B., et al. (2000) "Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects", British Journal of Haematology, 108, 805–816.
   PubMed Web of Science ®Google Scholar
• Cull, G., Durrant, L., Stainer, C., Haynes, A. and Russel, N.H. (1999) "Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myelo-ma", British Journal of Haematology, 107, 648–655.
   Google Scholar
• Lim, S.H. and Bailey-Wood, R. (1999) "Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma", International Journal of Cancer, 83, 215–222.
   Google Scholar
• Yi, Q., Desikan, R., Barlogie, B. and Munshi, N. (2002) "Optimizing dendritic cell-based immunotherapy in multiple mye-loma", British Journal of Haematology, 117, 297–305.
   Google Scholar
• Reichardt, V.L., Milazzo, C., Brugger, W., Einsele, H., Kanz, L. and Brossart, P. (2003) "Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells", Haematologica, 88, 1139 — 1149.
   Google Scholar
• Ratta, M., Curti, A., Fogli, M., Pantucci, M., Viscomi, G., Tazzari, P.L., et al. (2000) "Efficient presentation of tumor idiotype to autologous T-cells by CD83 + dendritic cells derived from highly purified circulating CD14 + monocytes in multiple myeloma patients", Experimental Hematology, 28, 931 — 940.
   Google Scholar
• Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Olivier°, B., et al. (2002) "Dendritic cells are functionally defective in multiple myeloma: The role of interleulcin-6", Blood, 100, 230 — 237.
   Google Scholar
• Motta, MR., Castellani, S., Rizzi, S., Curti, A., Gubinelli, F., Fogli, M., et al. (2003) "Generation of dendritic cells from CD14 monocytes positevely selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination", British Journal of Haematology, 121, 240–250.
   PubMed Web of Science ®Google Scholar
• Lemoli, R.M., Fortuna, A., Motta, MR., Rizzi, S., Giudice, V., Nannetti, A., et al. (1996) "Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: Positive selection and transplantation of enriched CD34 + cells to remove circulating tumor cells", Blood, 87, 1625–1634.
   Google Scholar
• Timmerman, J.M. and Levy, R. (2000) "Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine", Journal of Immunology, 164, 4797 — 4803.
   Google Scholar
• Goding, J.W. (1996) "Production and application of monoclonal antibodies in cell biology, biochemistry and immunology", Mono-clonal antibodies: Principle and practice (3rd Edition). Chapter 9. Pp. 209–219. London: Academic Press.
   Google Scholar
• Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., et al. (1997) "Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions", European Journal of Immunology, 27, 3135–3142.
   Google Scholar
• Thurner, B., Roder, C., Diecicman, D., Heuer, M., Kruse, M., Glaser, A., et al. (1999) "Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical applications", Journal of Immunological Methods, 223, 1— 15.
   Google Scholar
• Padley, D.J., Dietz, A.B., Gastineau, D.A. and Vuk-Pavlovic, S. (2001) "Mature myeloid dendritic cells for clinical use prepared from CD14 + cells isolated by immunomagnetic adsorption", Journal of Hematotherapy & Stem Cell Research, 10, 427–429.
   PubMedGoogle Scholar
• Brown, RD., Pope, B., Murray, A., Esdale, W., Sze, D.M., Gibson, J., et al. (2001) "Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD4OLT stimulation because of inhibition by transforming growth factor-B1 and interleulcin-10", Blood, 98, 2992–2998.
   PubMed Web of Science ®Google Scholar
• Gabrilovich, DI, Chen, H.L., Cunningham, H.T., Meny, G.M., Nadaf, S., Kavanaugh, D., et al. (1996) "Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells", Nature Medicine, 2, 1096–1103.
   Google Scholar
• Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. and Enk, A.H. (1997) "Induction of tolerance by IL-10-treated dendritic cells", Journal of Immunology, 159, 4772–4780.
   PubMed Web of Science ®Google Scholar
• Macatonia, S.E., Hosken, N.A., Litton, M., Viera, P., Hsieh, CS., Culpepper, J.A., et al. (1995) "Dendritic cells produce IL-12 and direct the development of TH1 cells from the naive CD4 + T cells", Journal of Immunology, 154, 5071–5079.
   PubMed Web of Science ®Google Scholar
• Bhardwaj, N., Bender, A., Gonzales, N., Bui, L.K., Garret, M.C. and Steinman, R.M. (1994) "Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8 + T cells", Journal of Clinical Investigation, 94, 797–807.
   PubMed Web of Science ®Google Scholar